Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
Welcome to the Cyrona Cell Podcast, your trusted source for clear, doctor-led conversations about stem cell therapy and regenerative medicine in Malaysia.
Hosted by the team at Cyrona Cell in Kuala Lumpur, this podcast explores how mesenchymal stem cells (MSCs), exosome support, and evidence-informed cell-based care may help patients living with chronic inflammation, immune imbalance, and long-term degenerative conditions.
We discuss:
• How stem cell therapy works in real clinical settings
• What current research supports — and what it does not
• Eligibility and safety screening for treatment
• Conditions such as osteoarthritis, diabetes, neurological disorders, autoimmune diseases, and more
• What international patients can expect when seeking treatment in Malaysia
• Realistic outcomes, risks, and ethical standards in regenerative medicine
At Cyrona Cell, we believe in honest medicine — not hype. Every episode focuses on transparency, medical screening, patient suitability, and integrating cell therapy into a broader treatment plan.
If you are considering stem cell therapy in Kuala Lumpur and want medically grounded information before making a decision, this podcast is designed for you.
New episodes are released regularly.
Cyrona Cell Podcast: Stem Cell Therapy in Malaysia
Stem Cell Therapy for Degenerative Disc Disease: What the New 2026 BRTX-100 Trial Data Really Means
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
New 2026 clinical trial data for BRTX-100 are drawing attention in regenerative medicine and spine care. Researchers are studying whether stem cell therapy can help treat chronic lumbar disc disease by reducing pain, improving function, and possibly supporting disc repair.
In this episode, we break down the latest Phase 2 BRTX-100 trial results, what they mean for patients with chronic low back pain, and why experts are still urging caution until the full unblinded data is released.
You’ll learn:
- What degenerative disc disease is and why it causes chronic low back pain
- Why current treatments often focus on symptom relief instead of repairing disc damage
- What BRTX-100 is and how this mesenchymal stem cell therapy is designed to work
- How autologous stem cells from bone marrow are used in regenerative medicine research
- The key 2026 Phase 2 trial results for pain reduction and disability improvement
- What VAS pain scores and ODI disability scores actually measure
- Why the blinded trial design is important before proving treatment effectiveness
- The safety findings reported in the BRTX-100 study so far
- Why has no stem cell therapy currently been approved by the FDA for disc disease or back pain
- How stem cell therapy compares with treatments like platelet-rich plasma PRP
- Whether stem cells can truly rebuild disc height and repair spinal discs
- What patients should know before considering commercial stem cell clinics or experimental treatments
The early BRTX-100 results look promising, especially for long-term pain relief and improved mobility. However, researchers still need unblinded Phase 2 data and larger Phase 3 trials before doctors can know whether this therapy truly works better than placebo treatment.
This episode explains the science, the limitations, and the future of stem cell therapy for degenerative disc disease in simple, easy-to-understand language.
Blog Link: Stem Cell Therapy for Degenerative Disc Disease: New 2026 Trial Data Explained